Development of new plasmid DNA vaccine vectors with R1-based replicons
There has been renewed interest in biopharmaceuticals based on plasmid DNA (pDNA) in recent years due to the approval of several veterinary DNA vaccines, on-going clinical trials of human pDNA-based therapies, and significant advances in adjuvants and delivery vehicles that have helped overcome earlier efficacy deficits. With this interest comes the need for high-yield, cost-effective manufacturing processes. To this end, vector engineering is one promising strategy to improve plasmid production.
In this work, we have constructed a new DNA vaccine vector, pDMB02-GFP, containing the runaway R1 origin of replication. The runaway replication phenotype should result in plasmid copy number amplification after a temperature shift from 30°C to 42°C. However, using Escherichia coli DH5α as a host, we observed that the highest yields of pDMB02-GFP were achieved during constant-temperature culture at 30°C, with a maximum yield of approximately 19 mg pDNA/g DCW being observed. By measuring mRNA and protein levels of the R1 replication initiator protein, RepA, we determined that RepA may be limiting pDMB02-GFP yield at 42°C. A mutant plasmid, pDMB-ATG, was constructed by changing the repA start codon from the sub-optimal GTG to ATG. In cultures of DH5α[pDMB-ATG], temperature-induced plasmid amplification was more dramatic than that observed with pDMB02-GFP, and RepA protein was detectable for several hours longer than in cultures of pDMB02-GFP at 42°C.
Overall, we have demonstrated that R1-based plasmids can produce high yields of high-quality pDNA without the need for a temperature shift, and have laid the groundwork for further investigation of this class of vectors in the context of plasmid DNA production.
- Kutzler MA, Weiner DB: DNA vaccines: ready for prime time? Nat Rev Genet 2008, 9:776–788. CrossRef
- Moore JP, Klasse PJ, Dolan MJ, Ahuja SK: AIDS/HIV. A STEP into darkness or light? Science 2008, 320:753–755. CrossRef
- Saade F, Petrovsky N: Technologies for enhanced efficacy of DNA vaccines. Expert Rev Vaccines 2012, 11:189–209. CrossRef
- Sardesai NY, Weiner DB: Electroporation delivery of DNA vaccines: Prospects for success. Curr Opin Immunol 2011, 23:421–429. CrossRef
- Lin-Chao S, Chen W, Wong T: High copy number of the pUC plasmid results from a Rom/Rop-suppressible point mutation in RNA II. Mol Microbiol 1992, 6:3385–3393. CrossRef
- Williams JA, Luke J, Langtry S, Anderson S, Hodgson CP, Carnes AE: Generic plasmid DNA production platform incorporating low metabolic burden seed-stock and fed-batch fermentation processes. Biotechnol Bioeng 2009, 103:1129–1143. CrossRef
- Soubrier F, Cameron B, Manse B, Somarriba S, Dubertret C, Jaslin G, Jung G, Caer CL, Dang D, Mouvault JM, Scherman D, Mayaux JF, Crouzet J: pCOR: a new design of plasmid vectors for nonviral gene therapy. Gene Ther 1999, 6:1482–1488. CrossRef
- Soubrier F, Laborderie B, Cameron B: Improvement of pCOR plasmid copy number for pharmaceutical applications. Appl Microbiol Biotechnol 2005, 66:683–688. CrossRef
- Uhlin BE, Molin S, Gustafsson P, Nordström K: Plasmids with temperature-dependent copy number for amplification of cloned genes and their products. Gene 1979, 6:91–106. CrossRef
- Nordström K: Plasmid R1—Replication and its control. Plasmid 2006, 55:1–26. CrossRef
- Givskov M, Stougaard P, Light J, Molin S: Identification and characterization of mutations responsible for a runaway replication phenotype of plasmid R1. Gene 1987, 57:203–211. CrossRef
- Ansorge MB, Kula M: Production of recombinant L-leucine dehydrogenase from Bacillus cereus in pilot scale using the runaway replication system E. coli[pIET98]. Biotechnol Bioeng 2000, 68:557–562. CrossRef
- Hoffmann I, Widstrom J, Zeppezauer M, Nyman PO: Overproduction and large-scale preparation of deoxyuridine triphosphate nucleotidohydrolase from Escherichia coli. Eur J Biochem 1987, 164:45–51. CrossRef
- Morino T, Morita M, Seya K, Sukenaga Y, Kato K, Nakamura T: Construction of a runaway vector and its use for a high-level expression of a cloned human superoxide dismutase gene. Appl Microbiol Biotechnol 1988, 28:170–175. CrossRef
- Kidwell J, Valentin H, Dennis D: Regulated expression of the Alcaligenes eutrophus pha biosynthesis genes in Escherichia coli. Appl Environ Microbiol 1995, 61:1391–1398.
- Remaut E, Tsao H, Fiers W: Improved plasmid vectors with a thermoinducible expression and temperature-regulated runaway replication. Gene 1983, 22:103–113. CrossRef
- Prather KJ, Sagar S, Murphy J, Chartrain M: Industrial scale production of plasmid DNA for vaccine and gene therapy: Plasmid design, production, and purification. Enzyme Microb Technol 2003, 33:865–883. CrossRef
- Węgrzyn G: Replication of plasmids during bacterial response to amino acid starvation. Plasmid 1999, 41:1–16. CrossRef
- Mizutani S, Iijima S, Kobayashi T: Fed-batch culture of Escherichia coli harboring a runaway-replication plasmid. J Chem Eng Jpn 1986, 19:111–116. CrossRef
- Light J, Riise E, Molin S: Transcription and its regulation in the basic replicon region of plasmid R1. Mol Gen Genet 1985, 198:503–508. CrossRef
- Nordström K, Uhlin BE: Runaway-replication plasmids as tools to produce large quantities of proteins from cloned genes in bacteria. Nat Biotechnol 1992, 10:661–666. CrossRef
- Kozak M: Regulation of translation via mRNA structure in prokaryotes and eukaryotes. Gene 2005, 361:13–37. CrossRef
- Masai H, Arai K: RepA protein- and oriR-dependent initiation of R1 plasmid replication: Identification of a rho-dependent transcription terminator required for cis-action of repA protein. Nucleic Acids Res 1988, 16:6493–6514. CrossRef
- Giraldo-Suárez R, Fernández-Tresguerres E, Díaz-Orejas R, Malki A, Kohiyama M: The heat-shock DnaK protein is required for plasmid R1 replication and it is dispensable for plasmid ColE1 replication. Nucleic Acids Res 1993, 21:5495–5499. CrossRef
- Gross CA: Function and regulation of the heat shock proteins. In Escherichia coli and Salmonella: Cellular and molecular biology. 2nd edition. Edited by: Neidhardt FC. Washington, DC: ASM Press; 1996:1382–1399.
- Klinman DM, Klaschik S, Tross D, Shirota H, Steinhagen F: FDA guidance on prophylactic DNA vaccines: Analysis and recommendations. Vaccine 2010, 28:2801–2805. CrossRef
- Pedelacq JD, Cabantous S, Tran T, Terwilliger TC, Waldo GS: Engineering and characterization of a superfolder green fluorescent protein. Nat Biotechnol 2006, 24:79–88. CrossRef
- Kozak M: An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res 1987, 15:8125–8148. CrossRef
- Bower DM, Lee KS, Ram RJ, Prather KLJ: Fed-batch microbioreactor platform for scale down and analysis of a plasmid DNA production process. Biotechnol Bioeng 2012, 109:1976–1986. CrossRef
- Livak K, Schmittgen T: Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods 2001, 25:402–408. CrossRef
- Zor T, Selinger Z: Linearization of the Bradford protein assay increases its sensitivity: Theoretical and experimental studies. Anal Biochem 1996, 236:302–308. CrossRef
- Development of new plasmid DNA vaccine vectors with R1-based replicons
- Open Access
- Available under Open Access This content is freely available online to anyone, anywhere at any time.
Microbial Cell Factories
- Online Date
- August 2012
- Online ISSN
- BioMed Central
- Additional Links
- Plasmid DNA
- DNA vaccines
- R1 replicon
- Runaway replication